Evidence map›Paper›PMID 27323807›Full record

ArticleOncotarget2016

Zingerone suppresses angiogenesis via inhibition of matrix metalloproteinases during tumor development.

Woom-Yee Bae, Jae-Sun Choi, Ja-Eun Kim, Chan Park, Joo-Won Jeong

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
5.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Woom-Yee BaeDepartment of Biomedical Science, Graduate School, Kyung Hee University, Seoul, 02447, Republic of Korea.
Jae-Sun ChoiDepartment of Biomedical Science, Graduate School, Kyung Hee University, Seoul, 02447, Republic of Korea.
Ja-Eun KimDepartment of Anatomy and Neurobiology, School of Medicine, Kyung Hee University, Seoul, 02447, Republic of Korea.
Chan ParkDepartment of Biomedical Science, Graduate School, Kyung Hee University, Seoul, 02447, Republic of Korea.
Joo-Won JeongDepartment of Biomedical Science, Graduate School, Kyung Hee University, Seoul, 02447, Republic of Korea.
Kyung Hee University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiogenesis is an essential step for tumor survival and progression, and the inhibition of angiogenesis is a good strategy for tumor therapeutics. In this study, we investigated the therapeutic effect of zingerone in a mouse tumor model. Zingerone suppressed tumor progression and tumor angiogenesis. Moreover, we found that zingerone inhibited the angiogenic activities of endothelial cells by both direct and indirect means. A mechanistic study showed that the activities of MMP-2 and MMP-9 in tumor cells were decreased by treatment with zingerone. Interestingly, zingerone-mediated inhibition of MMP-2 and MMP-9 was involved in the JNK pathway. In conclusion, zingerone showed strong anti-angiogenic activity via the inhibition of MMP-2 and MMP-9 during tumor progression, suggesting that zingerone may be a potential therapeutic drug for human cancers.

Indexed as

AnimalsCell Growth ProcessesDisease Models, AnimalGuaiacolHypoxia-Inducible Factor 1, alpha SubunitKidney NeoplasmsMaleMatrix Metalloproteinase 2Matrix Metalloproteinase 9Matrix Metalloproteinase InhibitorsMiceMice, Inbred BALB CNeovascularization, PathologicGuaiacolHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitMatrix Metalloproteinase 2Matrix Metalloproteinase 9Matrix Metalloproteinase InhibitorsMmp2 protein, mouseMmp9 protein, mousezingeroneangiogenesiscancerJNKmatrix metalloproteinaseszingerone

Identifiers

PMID27323807
PMCPMC5216937
OpenAlexW2430260503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.